Results 61 to 70 of about 760,216 (304)

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta, Jeremy D. Rubinstein, Christopher E. Dandoy, Ruby Khoury, Angela Faulhaber, Christine L. Phillips, Christa Krupski   +6 more
wiley   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma   +3 more
wiley   +1 more source

Analysis of Interactive E-Health Tools on United Arab Emirates Patient Visited Hospital Websites [PDF]

Healthcare Informatics Research, 2019
ObjectivesThis study is to scrutinize the website of Seoul National University Hospital in Korea, Clinique Valmont in Switzerland, Medical Center of the University of Munich in Germany, Cleveland Clinic Abu Dhabi in the United Arab Emirates (UAE) to ...
Yeong Joo Hong, Jeongeun Kim
doaj   +1 more source

Increased Risk of Sarcomas in Children With Congenital Anomalies: Findings From the Genetic Overlap Between Anomalies and Cancer in Kids (GOBACK) Registry Linkage Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters, Ji Yun Tark, Tiffany M. Chambers, Tania A. Desrosiers, Michael E. Scheurer, Charles Shumate, Wendy N. Nembhard, Mahsa M. Yazdy, Eirini Nestoridi, Amanda E. Janitz, Jean Paul Tanner, Russell S. Kirby, Jason L. Salemi, Yao Yu, Chad D. Huff, Sharon E. Plon, Philip J. Lupo, Jeremy M. Schraw   +17 more
wiley   +1 more source

Insights on pediatric medication initiation: perceptions of caregivers and children

Frontiers in Pharmacology
IntroductionChildren fail to initiate a high proportion of medications but little is known about motivations for non-initiation.ObjectiveTo explore the factors affecting the decision to initiate a medication prescribed to children from caregivers’ and ...
Maria Rubio-Valera, Maria Rubio-Valera, Maria Rubio-Valera, Maria Rubio-Valera, Cristina Carbonell-Duacastella, Cristina Carbonell-Duacastella, Maite Peñarrubia-María, Maite Peñarrubia-María, Maite Peñarrubia-María, Eva Pacheco, Eva Pacheco, Patricia Gabriela-Ricciardeli, Ignacio Aznar-Lou, Ignacio Aznar-Lou, Montserrat Gil-Girbau, Montserrat Gil-Girbau   +15 more
doaj   +1 more source

Supporting Survivor‐Centered Care Through Digital Health Integration

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak, Rebecca Williamson‐Lewis, Michael O'Connor, Michael Palgon, Yu‐Ra Kim, Michael Schuckenbrock, Paula Edwards, Abraham Mendoza, Anthony Adams, Brian Arriaga‐Solis, Justin Parker, Harry Tinoco‐Giraldo, Jason King, C. Michael Fordis, Karen E. Effinger, Maria Monica Gramatges   +15 more
wiley   +1 more source

The key actor: a qualitative study of patient participation in the handover process in Europe [PDF]

, 2012
Contains fulltext : 109871.pdf (Publisher’s version ) (Open ...
Ohlen, G., Toccafondi, Giulio, Johnson, J.K., Pijnenborg, L., Dudzik-Urbaniak, E., Gademan, P., Vernooij-Dassen, M.J.F.J., Schoonhoven, L., Vernooij-Dassen, M., Schoonhoven, Lisette, Dudzik-Urbaniak, Ewa, Olsson, M., Barach, P., Wollersheim, H., Hesselink, Gijs, Toccafondi, G., Vernooij-Dassen, Myrra, Flink, M., Olsson, Mariann, Wollersheim, H.C.H., Flink, Maria, Johnson, Julie K., Orrego, C., Hansagi, H., Oḧlén, Gunnar, Gademan, Petra J., Pijnenborg, Loes, Wollersheim, Hub, Orrego, Carola, Hesselink, G., Hesselink, G.J., Hansagi, Helen, Barach, Paul   +32 more
core   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Self-criticism of physicians, patient participation and risk competence

GMS German Medical Science, 2015
Self-criticism of physicians and patient participation are the pillars of modern medical ethics and medical programmes. Patients expect risk minimisation from physicians, mostly without realising how much they could actively do themselves in this respect.
Wolffsohn, Michael
doaj   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi, Daisuke Katagiri, Takeyuki Watadani, Shunichi Matsuda, Hiroshi Kaneko, Noritoshi Arai   +5 more
wiley   +1 more source